CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
114 hedge funds and large institutions have $209M invested in Cymabay Therapeutics in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more funds holding
Funds holding: 102 → 114 (+12)
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
Holders
114
Holding in Top 10
4
Calls
$2.07M
Puts
$1.69M
Top Buyers
| 1 | +$9.92M | |
| 2 | +$7.56M | |
| 3 | +$5.58M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$5.31M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.62M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$9.68M | |
| 3 | -$3.76M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.92M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.65M |